← Back to headlines

Weight-Loss Drug Semaglutide Approved in Tablet Form Across EU
The active ingredient Semaglutide, used in weight-loss medication, has received EU-wide approval for its tablet form, offering an alternative to injections.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


